Endogenous Endophthalmitis in the Inpatient Setting
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01323868|
Recruitment Status : Completed
First Posted : March 28, 2011
Last Update Posted : November 18, 2014
|Condition or disease|
Some patients admitted to the hospital have blood-borne infections. Occasionally, these blood infections can end up inside the eye and cause an infection inside the eye (called endogenous endophthalmitis).
Prior to modern and rapid treatment of systemic infections, the rate of endogenous endophthalmitis was reported to be 37% in 1982. By 1997, the rate was reported to be 2.8%. This study aims to determine the rate of endogenous endophthalmitis at Stanford Hospital in the modern medical era in that our rates may be different as those reported in the literature. This potential difference may be a reflection of treatment protocols and antibiotics currently in use at Stanford Hospital.
|Study Type :||Observational|
|Actual Enrollment :||145 participants|
|Official Title:||Endogenous Endophthalmitis Rates, Clinical Course, and Outcomes|
|Study Start Date :||July 2010|
|Actual Primary Completion Date :||June 2013|
|Actual Study Completion Date :||June 2013|
- Positive intraocular infection [ Time Frame: 1 day ]
- Visual acuity [ Time Frame: 2 wk ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01323868
|United States, California|
|Stanford University School of Medicine|
|Stanford, California, United States, 94305|
|Principal Investigator:||Theodore Leng||Stanford University|